Concerning natriuretic peptides (NPs), mainly B-type natriuretic peptide (BNP) and NTproBNP, they might be elevated in COVID-19 patients both due to the presence of pre-existing cardiac disease and the occurrence of acute hemodynamic stress related to COVID-19 pathogenesis [139]. The gene discussed is NPPB; the disease is heart disorder.